Hamartomatous polyposis syndromes
Zoran Stojcev1, Pawel Borun, Jacek Hermann
1Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, Poznan, 60-479, Poland. andp@man.poznan.pl.
Insights
Hamartomas are benign growths. Familial hamartomatous polyposis syndromes, like JPS and PJS, share symptoms, complicating early diagnosis and requiring molecular methods for effective cancer risk management.
Area of Science:
- Gastroenterology
- Oncology
- Genetics
Background:
- Hamartomas are disorganized tissue growths, often presenting as polyps.
- Familial hamartomatous polyposis syndromes include Juvenile Polyposis Syndrome (JPS), Peutz-Jeghers' Syndrome (PJS), Hereditary Mixed Polyposis Syndrome (HMPS), and PTEN Hamartoma Tumor Syndrome (PHTS).
- These syndromes are autosomal dominant and present heterogeneous polyp characteristics and cancer risks.
Purpose of the Study:
- To highlight the diagnostic challenges in differentiating various hamartomatous polyposis syndromes.
- To emphasize the importance of molecular diagnostics for timely and effective management.
- To underscore the need for vigilant monitoring of neoplastic transformation risks.
Main Methods:
- Review of clinical and genetic features of hamartomatous polyposis syndromes.
- Discussion of diagnostic similarities and differences.
- Emphasis on molecular diagnostic approaches.
Main Results:
- Hamartomatous polyposis syndromes often present with overlapping symptoms, particularly in early stages.
- Differential diagnosis based solely on clinical presentation can be challenging.
- Molecular diagnostics are crucial for accurate identification of specific syndromes.
Conclusions:
- Accurate diagnosis of hamartomatous polyposis syndromes is essential for personalized treatment strategies.
- Early and precise diagnosis facilitates effective management and monitoring.
- Molecular methods enable earlier intervention, improving outcomes and managing cancer predisposition.
Abstract:
Hamartomas are tumour-like malformations, consisting of disorganized normal tissues, typical of the site of tumour manifestation. Familial manifestation of hamartomatous polyps can be noted in juvenile polyposis syndrome (JPS), Peutz-Jeghers' syndrome (PJS), hereditary mixed polyposis syndrome (HMPS) and PTEN hamartoma tumour syndrome (PHTS). All the aforementioned syndromes are inherited in an autosomal dominant manner and form a rather heterogenous group both in respect to the number and localization of polyps and the risk of cancer development in the alimentary tract and other organs. Individual syndromes of hamartomatous polyposis frequently manifest similar symptoms, particularly during the early stage of the diseases when in several cases their clinical pictures do not allow for differential diagnosis. The correct diagnosis of the disease using molecular methods allows treatment to be implemented earlier and therefore more effectively since it is followed by a strict monitoring of organs that manifest a predisposition for neoplastic transformation.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Portal Hypertension
Appendicitis


